¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vascular signal void"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cerebral vascular resistance
    ³úÇ÷°üÀúÇ×
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
  • pulmonary vascular resistance
    ÆóÇ÷°üÀúÇ×
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üº´
  • peripheral vascular resistance
    ¸»ÃÊÇ÷°üÀúÇ×
  • renal vascular disorder
    ÄáÆÏÇ÷°üÀå¾Ö, ½ÅÀåÇ÷°üÀå¾Ö
  • reticulate vascular nevus
    ±×¹°Ç÷°ü¸ð¹Ý
  • splanchnic vascular bed
    ³»ÀåÇ÷°ü¿µ¿ª, ³»ÀåÇ÷°ü»ó
  • skin vascular permeability factor
    ÇǺÎÇ÷°üÅõ°úÀÎÀÚ
  • vascular
    1. Ç÷°ü- 2. ¸Æ°ü-
  • vascular access
    Ç÷°üÅë·Î
  • vascular bed
    Ç÷°ü»ó, Ç÷°ü¹ÙÅÁ
  • vascular cecal fold
    ¸·Ã¢ÀÚÇ÷°üÁÖ¸§
  • vascular cell adhesion molecule
    Ç÷°ü¼¼Æ÷ºÎÂøºÐÀÚ
  • vascular circle
    ¸Æ°ü°í¸®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • signal sequence
    ½ÅÈ£¼ø¼­
  • signal stimulus
    ½ÅÈ£ÀÚ±Ø
  • signal symptom
    °æ°íÁõ»ó
  • signal transduction
    ½ÅÈ£Àü´Þ
  • termination signal
    Á¾·á½ÅÈ£
  • tolerogenic signal
    ¸é¿ªÇã¿ëÀ¯¹ß½ÅÈ£
  • articular vascular network
    °üÀý¸Æ°ü±×¹°
  • concentric vascular bundle
    µ¿½É¸Æ°ü´Ù¹ß
  • splanchnic vascular bed
    ³»ÀåÇ÷°ü¿µ¿ª
  • vascular bed
    Ç÷°ü»ó, Ç÷°ü¹ÙÅÁ
  • cerebral vascular resistance
    ³úÇ÷°üÀúÇ×
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • coronary vascular resistance
    ½ÉÀåÇ÷°üÀúÇ×, °ü»óÇ÷°üÀúÇ×
  • vascular circle
    ¸Æ°ü°í¸®
  • hypertensive vascular disease
    °íÇ÷¾ÐÇ÷°üº´
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • signal amplitude
    ½ÅÈ£ ÁøÆø
  • signal anxiety
    ½ÅÈ£ºÒ¾È.
  • signal averaging
    ½ÅÈ£ Æò±Õ
  • signal channel
    ½ÅÈ£ Åë·Î
  • signal detection theory
    ½ÅÈ£°¨ÁöÀÌ·Ð
  • signal effects
    ½Åȣȿ°ú
  • signal homogeneity
    ½ÅÈ£ ±ÕÀϼº
  • signal intensity (SI)
    ½ÅÈ£ °­µµ
  • signal loss
    ½ÅÈ£ ¼Ò½Ç
  • signal oversampling
    ½ÅÈ£ °ú ÃßÃâ
  • signal peptide
    ½ÅÈ£ÆéƼµå
  • signal sequence
    ½ÅÈ£¼­¿­
  • signal stimuli
    ½ÅÈ£ÀÚ±Ø(ãáûÜô§Ð½).
  • signal symptom
    °æ°íÁõ»ó(ÌíͱñøßÒ)
  • signal to noise ratio (SNR)
    ½ÅÈ£ ´ë ÀâÀ½ºñ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • saturation of signal
    ½ÅÈ£Æ÷È­
  • signal
    ½ÅÈ£
  • signal alteration
    ½ÅÈ£º¯°æ
  • signal amplitude
    ½ÅÈ£ÁøÆø
  • signal averaging
    ½ÅÈ£Æò±Õ
  • signal channel
    ½ÅÈ£Åë·Î
  • signal homogeneity
    ½ÅÈ£±ÕÀϼº
  • signal intensity [=SI]
    ½ÅÈ£°­µµ
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • signal oversampling
    ½ÅÈ£°úÃßÃâ
  • signal to noise ratio [=SNR]
    ½ÅÈ£´ëÀâÀ½ºñ
  • SNR [=signal to noise ratio]
    ½ÅÈ£´ëÀâÀ½ºñÀ²
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DSP decreased sensory perception; delayed sleep phase; desmoplakin; dibasic sodium phosphate; digital si...
EPI/STAR echo planar imaging with signal targeting and alternating radiofrequency
ERK extracellular signal-regulated kinase
FIS forced inspiratory spirogram; free induction signal
IROS ipsilateral routing of signal
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
DSP Digital Signal Processing
DSP Digital Signal Processor
ERK2 Extracellular signal Regulated Kinase 2
ERK1 Extracellular signal-regulated kinase 1
ERK Extracellular signal-regulated protein kinase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vascular
    ¸Æ°ü¼º, Ç÷°ü¼º
    Ç÷°ü¿¡ °üÇÑ. ¸Æ°üÀÇ, Ç÷°üÀÇ, Ç÷°üºÐÆ÷¼ºÀÇ. ´Ù·®ÀÇ Ç÷¾× °ø±ÞÀÌ Ç³ºÎÇÔÀ» ³ªÅ¸³»´Â.
  • vascular access
    Ç÷°ü Á¢±Ù
    Ç÷°ü Áúȯ ½Ã Áúȯ ºÎÀ§¿¡ µµ´ÞÇϱâ À§ÇÑ Á¢±Ù. ¶Ç´Â Àå±â³ª ±â°ü µîÀÇ ¼ö¼úÀ» À§ÇØ Ç÷°üÀ» ÅëÇØ º´¼Ò¿¡ µµ´ÞÇÏ´Â Á¢±Ù.
  • vascular bed
    Ç÷°ü»ó
  • vascular cecal fold
    ¸·Ã¢ÀÚ Ç÷°ü ÁÖ¸§
  • vascular change
    ¸Æ°ü¼º º¯È­
  • vascular damage
    Ç÷°ü ¼Õ»ó
  • vascular disorder
    Ç÷°ü Àå¾Ö, Ç÷°ü¼º Àå¾Ö
  • vascular endothelial growth factor
    ¸Æ°ü ³»ÇǼ¼Æ÷ ¼ºÀå ÀÎÀÚ, Ç÷°ü ³»ÇǼ¼Æ÷ ¼ºÀå ÀÎÀÚ
  • vascular flap
    Ç÷°üÇÇÆÇ
  • vascular hamartoma
    Ç÷°ü °ú¿ÀÁ¾
  • vascular integrity
    Ç÷°ü ¿ÏÀü¼º
  • vascular layer
    ¸Æ°üÃþ, Ç÷°üÃþ
  • vascular layer of lens
    ¼öÁ¤Ã¼ ¸Æ°üÃþ
  • vascular malformation
    Ç÷°ü ±âÇü
  • vascular murmur
    Ç÷°ü ÀâÀ½
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
vascular anticoagulant <protein> Group of calcium-binding proteins that interact with acidic membrane phospholipids in membranes. They contain 4 or 8 repeats of a 61 amino acid domain that folds into 5 a helices.
Also known by several other names (e.g. Lipocortins, endonexins), reflecting the history of their discovery in different contexts.
See: lipocortin, endonexin I & II, calpactin, p70 and calelectrin.
(18 Nov 1997)
vascular bud An endothelial sprout arising from a blood vessel.
(05 Mar 2000)
vascular bundle Strand of vascular tissue in a plant, composed of xylem and phloem.
(18 Nov 1997)
vascular cambium Lateral meristem that forms the secondary tissue and is located between the xylem and phloem.
(09 Oct 1997)
vascular capacitance The relationship between the volume of blood contained within a segment of vasculature and the pressure distending the vascular walls over a wide range of pressures and volumes. The veins of the body are not only conduits for the return of blood to the right heart, but they also determine most of the vascular capacitance and contain most of the blood volume. Changes in vascular capacitance provide a quick and effective mechanism for the filling of the right heart, thereby influencing cardiac output. Vascular capacitance is somewhat analogous to vascular resistance but whereas vascular resistance relates to flow through a blood vessel, vascular capacitance relates to the volume contained in it.
(12 Dec 1998)
vascular cataract Congenital cataract in which the degenerated lens is replaced with mesodermal tissue.
Synonym: cataracta adiposa, cataracta fibrosa.
(05 Mar 2000)
vascular cell adhesion molecule-1 Cytokine-induced cell adhesion molecule present on activated endothelial cells, tissue macrophages, dendritic cells, bone marrow fibroblasts, myoblasts, and myotubes. It is important for the recruitment of leukocytes to sites of inflammation.
(12 Dec 1998)
vascular circle The circle around the mouth formed by the inferior and superior labial arteries.
Synonym: areolar venous plexus.
(05 Mar 2000)
vascular circle of optic nerve <anatomy, nerve> A network of branches of the short ciliary arteries on the sclera around the point of entrance of the optic nerve.
Synonym: circulus vasculosus nervi optici, circulus arteriosus halleri, circulus zinnii, Haller's circle, Zinn's corona, Zinn's vascular circle.
(05 Mar 2000)
vascular cones The coiled portion of the efferent ductules that constitute the head of the epididymis; these join the ductus epididymidis.
Synonym: lobuli epididymidis, coni epididymidis, coni vasculosi, Haller's cones, vascular cones.
(05 Mar 2000)
vascular dementia A state of diminished cognition that is the results from repeated cerebral strokes with a step-like deterioration in intellectual functions with focal neurological signs, as the result of multiple infarctions of the cerebral hemispheres.
Synonym: multi-infarct dementia.
(07 Mar 2000)
vascular dentin Dentin in which the primitive capillaries have remained uncalcified and so are wide enough to give passage to the formed elements of the blood.
Synonym: vascular dentin.
(05 Mar 2000)
vascular endothelial growth factor A growth factor that is responsible for the growth of blood vessels.
(12 Dec 1998)
vascular fistula <surgery> An abnormal passage in a blood vessel, between two or more arteries, or between an artery and a vein.
(12 Dec 1998)
vascular fold of the caecum <anatomy> A peritoneal fold that arches over a branch of the ileocolic artery and bounds in front a narrow recess, the superior ileocaecal (or ileocolic) recess.
Synonym: plica caecalis vascularis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á